Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cocaine-Related Disorders
Intervention: Risperidone (Drug)
Phase: Phase 2
Status: Terminated
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s):
Lawrence Price, M.D., Principal Investigator, Affiliation: Brown University
Summary
The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study
measures incorporate an appropriate integration of behavioral and neurobiological indices.
Clinical Details
Official title: Serotonin/Dopamine Antagonism of Cocaine Effect
Study design: Treatment, Randomized, Double-Blind
Primary outcome: Analog mood scalesPOMS EPS sx
Eligibility
Minimum age: 18 Years.
Maximum age: 50 Years.
Gender(s): Both.
Criteria:
Please contact site for information.
Locations and Contacts
Brown University School of Medicine, Providence, Rhode Island 2906, United States
Additional Information
Starting date: August 1994
Last updated: June 23, 2005
|
